Personalized Medicine Conference with Nobel Prize Laureates Participation to Be Held in Dubrovnik, Croatia

Zagreb/Washington D.C., April, 25th, 2017. International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital in partnership with Philips are organizing “The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine” (www.isabs.hr), to be held in Dubrovnik, June 19th - June 24th, 2017. The 10th ISABS Conference is considered to be one of the most important scientific events in biomedicine in 2017. The conference topics includes: personalized and regenerative medicine, pharmacogenetics, molecular diagnostics, stem cell therapy, epigenetics, microbiome, cancer genetics, forensic and anthropological genetics, etc. During the ISABS 2017 Conference we would like to envision the power and advances of personalised medicine that will create significant value for the healthcare system. More than 50 invited speakers (including Nobel Prize Laureates) from the World’s best scientific institutions as well as 500 participants will attend the Conference.

Mayo Clinic, according to U.S. News & Word Report, is the #1 hospital overall, as well as #1 in more specialties than any other hospital in the United States.

International Society for Applied Biological Sciences (ISABS) is a member of the Association Academy of the American Academy of Forensic Sciences and one of the most important and influential society in the field of forensic genetics and personalised medicine. ISABS Scientific Committee comprise four Nobel Prize laureates and many of the world’s top physicians and scientists.

St. Catherine Hospital is a European center of excellence, a finalist of the European Business Award and a member of the prestigious group "The Leading Hospitals of The World".

Royal Philips, a leading global company in health technology, is focused on improving people's health and enabling better outcomes with meaningful innovations. Philips is shaping the future of personalized medicine with tools and services that enable patient-specific care with first-time-right decision-making and targeted therapy.

Link: ISABS